[1]

Van PH, Thieu NQ, Loi CB, et al. Cerebral cysticercosis presenting with recurrent epileptic seizures[J/OL]. Cureus, 2020, 12(5): e8153[2023-07-03]. https://www.cureus.com/articles/31702-cerebral-cysticercosis-presenting-with-recurrent-epileptic-seizures#!. DOI: 10.7759/cureus.8153.

[2] Batta A, Mahesh KV, Prabhat N, et al.  Newer magnetic resonance imaging techniques in neurocysticercosis[J]. Neuroradiol J, 2020, 33(6): 538-544.   doi: 10.1177/1971400920949394
[3]

Butala C, Brook TM, Majekodunmi AO, et al. Neurocysticercosis: current perspectives on diagnosis and management[J/OL]. Front Vet Sci, 2021, 8: 615703[2023-07-03]. https://www.frontiersin.org/articles/10.3389/fvets.2021.615703/full. DOI: 10.3389/fvets.2021.615703.

[4] Singh AK, Garg RK, Gupta RK, et al.  Dynamic contrast-enhanced (DCE) MRI derived kinetic perfusion indices may help predicting seizure control in single calcified neurocysticercosis[J]. Magn Reson Imaging, 2018, 49: 55-62.   doi: 10.1016/j.mri.2018.01.001
[5] Sharabi S, Last D, Daniels D, et al.  The effects of point-source electroporation on the blood-brain barrier and brain vasculature in rats: an MRI and histology study[J]. Bioelectrochemistry, 2020, 134: 107521-.   doi: 10.1016/j.bioelechem.2020.107521
[6] 贺春燕, 高岩峰.  乳腺癌不同分子亚型的动态对比增强MRI影像学特征分析及ADC特点研究[J]. 国际放射医学核医学杂志, 2021, 45(7): 427-433.   doi: 10.3760/cma.j.cn121381-202103035-00081
He CY, Gao YF.  Analysis of dynamic contrast-enhanced MRI image and apparent diffusion coefficient features of different molecular subtypes of breast cancer[J]. Int J Radiat Med Nucl Med, 2021, 45(7): 427-433.   doi: 10.3760/cma.j.cn121381-202103035-00081
[7] Hanael E, Veksler R, Friedman A, et al.  Blood-brain barrier dysfunction in canine epileptic seizures detected by dynamic contrast-enhanced magnetic resonance imaging[J]. Epilepsia, 2019, 60(5): 1005-1016.   doi: 10.1111/epi.14739
[8] Huang WY, Wu G, Li JJ, et al.  Early prediction of functional outcome using dynamic contrast enhanced magnetic resonance imaging in experimental stroke[J]. Magn Reson Imaging, 2016, 34(7): 1000-1007.   doi: 10.1016/j.mri.2016.04.015
[9] 中华医学会神经病学分会脑电图与癫痫学组.  成人癫痫诊断和药物治疗规范(草案)[J]. 中华内科杂志, 2006, 45(10): 875-877.
Electroencephalogram and Epilepsy Group of the Neurology Branch of the Chinese Medical Association.  Diagnosis and drug treatment guidelines for adult epilepsy (draft)[J]. Chin J Intern Med, 2006, 45(10): 875-877.
[10] Espino PH, Couper RG, Burneo JG.  An update on neurocysticercosis-related epilepsy[J]. Clin Neurol Neurosurg, 2022, 213: 107139-.   doi: 10.1016/j.clineuro.2022.107139
[11] Herrick JA, Bustos JA, Clapham P, et al.  Unique characteristics of epilepsy development in neurocysticercosis[J]. Am J Trop Med Hyg, 2020, 103(2): 639-645.   doi: 10.4269/ajtmh.19-0485
[12]

Takayanagui OM, de Haes TM. Update on the diagnosis and management of neurocysticercosis[J]. Arq Neuropsiquiatr, 2022, 80(5 Suppl 1): S296-306. DOI: 10.1590/0004-282X-ANP-2022-S115.

[13] Varatharaj A, Liljeroth M, Darekar A, et al.  Blood-brain barrier permeability measured using dynamic contrast-enhanced magnetic resonance imaging: a validation study[J]. J Physiol, 2019, 597(3): 699-709.   doi: 10.1113/JP276887
[14] Alpcan A, Bayar Muluk N, Inal M, et al.  Peripheral and central smell regions in children with epilepsy: an MRI evaluation[J]. J Clin Neurosci, 2022, 95: 99-105.   doi: 10.1016/j.jocn.2021.12.001
[15] Heye AK, Thrippleton MJ, Armitage PA, et al.  Tracer kinetic modelling for DCE-MRI quantification of subtle blood-brain barrier permeability[J]. NeuroImage, 2016, 125: 446-455.   doi: 10.1016/j.neuroimage.2015.10.018
[16] Bae J, Zhang J, Wadghiri YZ, et al.  Measurement of blood-brain barrier permeability using dynamic contrast-enhanced magnetic resonance imaging with reduced scan time[J]. Magn Reson Med, 2018, 80(4): 1686-1696.   doi: 10.1002/mrm.27145
[17] Lin ZX, Lance E, McIntyre T, et al.  Imaging blood-brain barrier permeability through MRI in pediatric sickle cell disease: a feasibility study[J]. J Magn Reson Imaging, 2022, 55(5): 1551-1558.   doi: 10.1002/jmri.27965
[18] Bergamino M, Barletta L, Castellan L, et al.  Dynamic contrast-enhanced MRI in the study of brain tumors. Comparison between the extended Tofts-Kety model and a phenomenological universalities (PUN) algorithm[J]. J Digit Imaging, 2015, 28(6): 748-754.   doi: 10.1007/s10278-015-9788-2
[19] Sahoo P, Rathore RKS, Awasthi R, et al.  Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI[J]. J Magn Reson Imaging, 2013, 38(3): 677-688.   doi: 10.1002/jmri.24021
[20] Barnes SR, Ng TSC, Montagne A, et al.  Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRI[J]. Magn Reson Med, 2016, 75(5): 1967-1977.   doi: 10.1002/mrm.25793